Tag: Asia Pacific at the forefront of decentralized
Asia Pacific at the forefront of decentralized clinical trials
By Edwin Ng, Senior Vice President, Asia Pacific, Life Science, Dassault Systèmes Clinical trials industry has been moving towards decentralisation post the pandemic and Asia-Pacific, given its strategic importance for global healthcare firms, availability of diverse pool of clinical trial […]